Enveda

Boulder, CO · Founded 2019 · Privately Held (backing)

Developer of a drug analysis platform designed to capitalize on the chemical diversity and evolutionary significance of natural samples. Enveda is based in Boulder, CO and was founded in 2019. It was valued at $2 billion at its Series E in Sep 2026, the last priced event on record. It has raised $530 million across 1 recorded round; the latest was a $311 million Series E in Sep 2026.

PMV mark · valuation
$2.0B
Oct 2026
Priced at
its Series E
Sep 2026
Total raised
$530.0M
Last round
Series E
Sep 2026

Who backs Enveda?

47 investors
InvestorType
Lightspeed Venture PartnersVenture capital
GaingelsVenture capital
Lux CapitalVenture capital
Village GlobalOther
True VenturesVenture capital
Kevin MooreAngel
Microsoft—
Baillie GiffordGrowth equity
Catalio Capital ManagementVenture capital
T. Rowe Price Group—
+ 37 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Enveda investors

47 investors are on record for Enveda, including Lightspeed Venture Partners, Gaingels, Lux Capital and Village Global. By type, the record holds 13 venture capital firms, 3 hedge funds and 3 growth equity firms. The Series E in Sep 2026 drew 16 investors.

Free account
More of Enveda with a free account
  • ·The post-money valuation on its round
  • ·The complete investor list: 47 names
  • ·Watch Enveda: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 47 firms already write checks for companies like Enveda. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View